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Skin extracts of South Amcricun hylid frogs of the subfamily Ph~~Ilomedusin~c contain dermorphins and dcltorphins, opioid hcptapcptidcs highly 
sclcctivc for either y or 6 receptors. In all thcsc peptides. a D-amino acid is present in the second position. The structure of the precursors for 
Ala-de~torphins was recently deduced from cioncd cDNAs derived from skin of Ph~/h~~m&~u blcolor (Richter et al. (1990) Proc. Natl. Acad. Sci. 
USA 87,4836-4839). From the amino acid sequence of these precursors, the cxistencc of three peprides related to dcrmorpltin could be predicted, 
From methanol extracts of skin of PII, biro/or WC have isolated two of these peptides, [Lys’ldcrmorphin-OH and [Trp’,Asn’jdurmorphinbH. The 
biolo~icai activity of these new dermorpl~ins and their an~idated counterparts i presented. 
Amphibian skin; Dcrmorphin; Dultorphin; Opioid pcptidc 
1. INTRODUCTION The described peptides have the following sequences: 
Dermorphin and deltorphin arc naturally occurring 
heptapeptides purified from skin extracts of the South 
American frog Phyllornedusa suuvugei [I,21 that show 
high affinity and selectivity for y and S opioid receptors, 
respectively. They share a similar N-terminal tripeptide 
sequence Tyr-o-Xaa-Phe, where o-Xaa is either o-Ala 
~dermorphin) or D-Met ~deltorphin), and have an ami- 
dated COOH terminus. Using a cDNA library prepared 
from the skin of Pit, sauvagei, the amino acid sequence 
of several dermorphin precursors was deduced, one of 
which contained the genetic information also for deltor- 
phin [33, now referred to as met-deItorphin. It was 
shown that the D-alanine or the D-methionine present in 
the final products were encoded by a normal codon for 
L-alanine or L-methionine, respectively. Two novel hep- 
tapeptides were subsequently isolated from skin extracts 
of the Amazonian frog Plqv(lorne&a bicofor that exhib- 
ited an even higher affinity for S opioid receptors: they 









Recently, the structure of four precursors for Ala- 
deltorphins I and II could be deduced from cloned 
cDNAs derived from the skin of Ph, bicoior [S]. These 
polypeptides contained one copy of Ala-deltorphin II, 
and either one, three or no copies of Ala-deltorphin I, 
respectively. In each case, a normal GCG codon for 
t=alanine was found in those positions where a r>-alani- 
ne is present in the end product. Moreover, the cDNA 
sequences revealed that a glycine residue required for 
the formation of the COOH-terminal amide was present 
after the AIa-deltorphin sequences, as it was after the 
met-deltorphin and dermorphin sequences determined 
earlier [3]. From the amino acid sequences of the Ala- 
deltorphin precursors, the existence of three additional 
peptides related to dermorphin could be predicted. Due 
to the absence of glycine at the COOH terminus of these 
peptides, they should contain a free a-carboxyl group. 
Abbrcvlurions: GPI, guinea-pig intestine; MVD, mouse vas dcfercns; 
DAGO, DAGMO, Typo-Ala-Gly-Phc(Me)-Oly-ol 
Cw~qondcm mldresss: D. Barra, Dipurtimcnto di Scicnxe Biochim- 
iche, Universith La Sapienza, Piazzale Aldo Moro 5, 00185 Rorna, 
Italy. Fax: CD) (6) 444100622. 
in this paper we descrik the isoktion of two of the 
three predicted peptides from methanol extracts of the 
skin of P/z. ~~c~~ur. The biological activity of these new 
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dermorphins and their amidated counterparts is pre- 
sented. 
2. MATERIALS AND METHODS 
Fresh skins (92 g) obtained from eight frogs captured near Oberii 
(Parand. Brazil) were minced with scissors and extracted with 500 ml 
of methanol for I week at room temperature. The liquid wus decanted 
and filtered, and the skin was extracted again with 5 parts (v/w) ofEO% 
methanol. The filtrates were combined and stored in a dark bottle at 
2°C until processed further, Most of this material was used earlier for 
the isolation and characterization of phyllomedusin 161, phyllocae- 
rulcin [7], phyllokinin [8] and Ala-deltorphins [4], 
A volume of the filtered extracts corresponding to2 g of fresh skin 
was lyophilized. redissolved inwater, and then fractionated by HPLC 
on a Beckman model 332 system using a reverse-phase column 
(Aquapore RF-300, 7 x 250 mm, Brownlee Labs, Applied Bio- 
systems) eluted with a 60-min gradient of O-30% acetonitrile in 0.2% 
(by vol.) trifluoroacetic acid, at a flow of 20 ml/min. Elution of the 
peptides was monitored on a Beckman 160 spectrophotomctcr at 214 
nm. In correspondence with each absorbance peak the effluent was 
collected in B tube and lyophilized. A 1% aliquot of:he material from 
each tube was then used for assay of biologicul activity. 
The eluate of the HPLC column was tested for inhibitory action 
(IC,, concentration producing 50% inhibition) on electrically evoked 
contractions in isolated preparations ofmyenteric plexus-longitudinal 
muscle obtained from the small intestine of guinea-pig (GPI) and 
prcparahons ol’vas defercns of mice (MVD) fl]. The synthetic refer- 
ence peptide was dermorphin. The PI;, hicolor dcrmorphins were first 
tested on the MVD preparation, which is insensitive to contaminating 
stimulatory peptides. and subsequently on the guinea-pig ileum, which 
does not respond to deltorphins. To further characterize the frog 
dermorphins, biotssays were performed in the presence or abscncc 01 
naloxone and the 6 receptor antagonist naltrindole [IO]. The GPI and 
MVD preparutions were also used in parallel assays to test lhe activity 
of synthetic Plr. bicolor dermorphins (both dcamidatcd and amidatcd 
forms), dcrmorphin and some dcrmorphinslike pcptides as well as 
other opiate compounds (see Table II). 
Amino acid analyses were performed with a Pharmaciu Alpha Plus 
4151 analyzer ufter vapor phase hydrolysis of the peptides (l-2 nmol) 
in 6 N HCI for 24 h. Peptide sequences were determined by automated 
Edman degradation with an Applied Biosystems model 475A gas- 
phase sequencer. The presence of a o~amino acid in the sequence was 
confirmed by reaction with n-amino acid oxidose (Sigma) as reported 
[4l, The presence of a free a-carboxyl group was determined from the 
elcctrophoretic mobility of the pcptides at pH 6.5 according to Offord 
[I I] wd by mass spectrometry. 
Peptides were prepared by solid-phase synthesis on a Pharmacia 
Biolynx automated peptide synthesizer according to fluoren-9. 
yltnethoxycarbonyl (Fmoc)-polyamidcactivc ester chemistry [ 121. The 
products were purified by reverse-phase HPLC and the expected 
amino acid scqucnces were confirmed by automated Edman dcgrada- 
tion. 
3. RESULTS AND DISCUSSION 
The elution profile from the HPLC column of the 
peptides from the skin extract of Ph. bicolor is shown 
in Fig. 1. Each fraction was tested for biological activity 
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Fig. I, Rcvcrsc-phase HPLC of a methanol extract from the skin of 
P/I. hicolor’. Peaks I through 8 were analyzed further (xc Table I), 
on the guinea-pig ileum and the mouse vas deferens. 
The dermorphin-like activity was present in peaks 1 and 
8, while deltorphin-like activity was found in peaks 4 
and 5 (see Fig. I). In peaks 2. 3 and 6 a stimulatory 
activity on guinea-pig ileum was detected. From the 
amino acid composition of these fractions (see Table I) 
it was obvious that peak 2 corresponds to phyllome- 
dusin 161, peak 3 to phyllocaerulein [7], peak 4 to Ala- 
deltorphin II, peak 5 to Ala-deitorphin I [4], and peak 
6 to phyllokinin [83, 
The amino acid sequences of the dermorphin-like 
peptides present in peaks 1 and 8 were determined. 
These were found to be Tyr-Ala-Phe-Gly-Tyr-Pro-Lys 
(peak I) and Tyr-Ala-Phe-Trp-Tyr-Pro-Asn (peak 8). 
The electrophoretic mobility of both peptides was con- 
sistent with the presence of a free a-carboxyl group. 
This result was also confirmed by fast-atom-bombard- 
ment mass spectral analysis (W/Z 845 and 960, respec- 
tively, for the two peptides). Comparison of amino acid 
analyses performed on acid hydrolysates of the peptides 
before and after treatment with n-amino acid oxidase 
confirmed the presence of a o-alanine in both peptides. 
Consequently, the two novel peptides were named 
[Lys’]dermorphin-OH and [Trp’,Asn’]dermorphin- 
OH, respectively. 
In the extract from the skin of Ptr. bidor the dermor- 
phin pentapeptide Tyr-p-Ala-Phe-Trp-Asn-OH, also 
predicted from the sequence of the cloned cDNAs, 
could not be detected as a distinct chromatographic 
peak or by bioassay. This may be due to the low content 
of this peptidc as well as to its relatively low biological 
activity (see below). 
The peptide present in peak 7 was devoid of any 
biological activity on isolated smooth muscle prepara- 
tions. Its amino acid composition (see Table I) does not 
correspond to any known peptide. As automated 
Edman degradation gave no results, the peptide was 
treated with 1 N HCl in methanol at 22OC for 24 h [I31 
to hydrolyze pyroglutamyl residues. After this treat- 
ment, the fo!lowing sequence cou!d be obtained: G!p- 
Glu-Lys-Pro-Phe-Tyr-Pro-Pro-Pro-Ile-Tyr-Pro-Val. 
The electrophoretic mobility of tht peptide and the re- 
sult of mass spectral analysis @z/z 1557) was consistent 
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Amino acid composhion of pcptidcs purified from Plr. hicoolo~ skin cxwac~ 
Amino acid Pcpddc 
I 2 3 4 5 6 7 8 
Aspariic acid 2.0 (2) I.1 (I) 0.8 (1) 1.1 (I) 
Serinc I,0 (1) I.0 (I) 
Glutamic acid 1.0 (I) 2.0 (2) 0.9 (I) 2.4 (2) 
Proline I.5 (I) I.1 (1) 2,7 (3) 5.2 (5) 1.2 (1) 
Glycinc I.6 (I) 1.2 (I) I.0 (I) 0.8 (I) 0.8 (1) I.2 (I) 1.3 (I) 0.9 (1) 
Alaninc I.5 (I) I.0 (I) 0.9 (I) 
Valine I .9 (2) I.8 (3) 
Methioninc 0.4 (I) 0.9 (I) 
Isoleucinc 0.8 (I) 1.1 (I) 1.2 (I) 
Leucine I.0 (I) 
Tyrosinc 2.9 (2) 1.0 (I) 0.9 (1) 0.8 (I) 0.9 (I) 0.9 (I) I.8 (2) 
Phenylalaninc I.% (I) 1.0 (I) 1.1 (I) I.0 (I) 0.9 (1) 2.1 !2) I.2 (I) I.2 (1) 
Lysinc 1.4 (I) 1.1 (I) 
Argininc 0.8 (Ii I.8 (2) 
Tryptophan ++ (I) ++ (1) 
The composition from sequence analysis or each peptide is indicaud by the numbers in parcmheses. Prescncc of tryptophan was indicated 
by absorbance at 280 nm and Ehrlich rcacrion. Peptide numbering refers 10 lhc peaks in Fig. I. (I) [Lys’]dcrmorphin.OH; (2) phyllomedusin [7]; 
(3) phyllocacrulein [S]; (4) Ala-dclturphin II [4]; (5) Ala-dcltorphin I [4]; (6) [HypJ.SeP]phyllokinin [9]; (7) tryplophyllin.like peptidc; 
(8) [TrpJ.Asn7]dermorphin-OH. 
with the presence of a free a-carboxyl group. The se- 
quence of this peptide is similar to that reported by 
Montecucchi et al. [14] for a tridecapeptide isolated 
from P/I. roltdei skin extracts, belonging to the class of 
the so- called tryptophyllins. However, in the peptide 
from Ph. bicolor, besides two additional substitutions, 
the tryptophan residue in position 5 was replaced by a 
tyrosine. 
The results of parallel bioassays of the natural der- 
morphins and a number of synthetic analogs are pre- 
sented in Table Ii. fn each case, the peptides with a free 
Table II 
Inhibitory polcnay (IC,,) or natural dcrmorphins, their amidatcd 
forms, DAGO and morphine on cleclrically evoked contractions of 
mouse vas dcfcrens (MVD) and guinea-pig ileum (GPI) prcparalions 
Peptide I&, nM [mean t S.E.M. (II)] MVDI 
GPI 
MVD GPI 
Dermorphin (Derm) 16.5 + I.8 (68) I.29 -c 0.09 (8) 12.8 
Dcrm-OH 28.1 z!z 2.4 (5) 4.5 2 0.32 (5) 6.24 
[Hypb]Derm 18.1 + 2.9 (5) I.6 2 0.12 (4) 11.3 
[Hyp6]Derm-OH 33.1 ?r 2.0 (4) 5.16 + 0.4 (4) 6.4 
[Lys’]Derm 13.6+ l.5(22) l.lSaO.l3 (22) II.8 
[Lys’]Dcrm-OH 56.3 + 7.8 (15) 3.8 2 0.45 (10) 14.7 
prp’,Asn’]Derm 6.6 f 0.9 (23) 0.58 + 0.06 (18) Il.4 
[TrpJ,Asn’]Derm-OH 10.4+ 1.3 (II) I.3 20.2 (IO) 8.0 
ITrp”,Asn’]DermIl-51 73.7 ?I 9.1 (IO) 5.3 kO.52 (13) 14.6 
[Trpa.Asn5]Derm[l-5]OH 205.2 ?: 25.4 (13) 13.1 ?I I.2 (IO) 15.6 
Dermil-51 21.4 2 3.1 (IO) 2.47 + 0.3 (9) 8.7 
DAGO 115.0~21.0(10) 7.1 kO.9 (IO) i6.2 
Morphine 793.0+97.0(15)51.6 27.3 (I?) 15.4 
In parcnlhescs i the number of cxpcrimcnls 
a-carboxyl group at the COOH terminus and the corre- 
sponding amides were tested. For comparison, the 
results obtained with dermorphin [I-5], DAGO 
(DAGMO: Tyr-D-Ala-Gly-Phe(Me)-Gly-01) and mor- 
phine were included in the table. 
From these data the following conclusions can be 
drawn: 
(a) dermorphin, [Hyp’ldermorphin and [Lys’ldermor- 
phin are approximately equiactive both on MVD 
and GPI preparations; 
(b) [Trp4, Asn’ldermorphin is 3 times more potent than 
the other three dermorphins; 
(c) the dermorphin pentapeptide prp’, Asn5] is 8 to 11 
times less potent than the corresponding heptapep- 
tide [Trp’, Asn’] and is also less potent han dermor- 
phin[l-51; 
(d) the deamidated peptides arc 2 to 4 times less potent 
than the corresponding amidated forms. Deamida- 
tion may produce a very slight shift of selectivity 
towards 6 receptors (decreased MVD/GPI ratio). 
(e) DAGC) was 5-6 times less potent than dermorphin 
and morphine 40 times less potent, with similar 
MVD/GPl ratios. 
It should be noted that the preservation of the activity 
and selectivity towards ,u receptors of dermorphins is 
not significantly compromised by either deamidation or 
shortening of the peptide chain. Conversely, the affinity 
of Ala-deltorphins for 6 receptors is drastically reduced 
by these changes, each causing at least a 30.fold de- 
crease. For example, Ala-deltorphin I [ 1 -S]-OH is about 
3000 times less potent than the corresponding amidated 
heptapeptide [ IS]. 
On the basis of amino acid analysis and bioassay we 
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estimate that one gram of fresh skin of P/t. b/color con- 
tains about 25 ,ug of [Lys’ldermorphin-OH and 68 pg 
of [Trp4, Asn’] dermorphin-OH. The total amount of 
dermorphins present in the skin of Ph. bidor is thus 
similar to that found in other Phyllomedusinae [16]. 
It is finally worth mentioning that in radioimmunoas- 
says with an anti-dermorphin serum, skin extracts from 
Ph. bicolm gave completely negative results (unpub- 
lished observations). Obviously, this antiserum did not 
cross-react with the Ph. bicoior dermorphins, and this 
retarded the identification of these novel peptides. 
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